Completed OBSERVATIONAL NCT01197872

Clinical Use of Parental Support To Detect Single Gene Mutations

Phase II: Clinical Use of Parental Support To Detect Single Gene Mutations

Sponsor: Natera, Inc.

Interventions Preimplantation Genetic Diagnosis

Updated 10 times since 2017 Last updated: Jul 12, 2013 Started: Sep 30, 2010 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01197872, this observational or N/A phase trial focuses on Single Gene Disorders and remains completed. Sponsored by Natera, Inc., it has been updated 10 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Natera, Inc.

Data source: Natera, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Redwood City, United States